| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/01/2001 | WO2001006854A1 System and methods for local intradermal treatment |
| 02/01/2001 | WO2000067735A3 USE OF SELECTIVE ANTAGONISTS OF THE α1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION |
| 02/01/2001 | WO2000061116A3 Pharmaceutical formulation comprising amoxycillin and clavulanate |
| 02/01/2001 | WO2000059518A3 Composition and method for inducing apoptosis in prostate cancer cells |
| 02/01/2001 | WO2000059493A3 Improved dialysis solutions and methods |
| 02/01/2001 | WO2000054764A3 A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications |
| 02/01/2001 | WO2000051583A3 Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or h2 receptor antagonists |
| 02/01/2001 | WO2000050022A3 Treatment regimen for hormone-sensitive cancers |
| 02/01/2001 | WO2000050017A3 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases |
| 02/01/2001 | WO2000047194A3 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR |
| 02/01/2001 | WO2000044906A3 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI) |
| 02/01/2001 | WO2000042832A3 New compounds for the treatment of cancer |
| 02/01/2001 | WO2000040226A3 Method of treating sexual disturbances |
| 02/01/2001 | WO2000038717A3 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 02/01/2001 | WO2000037107A3 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 02/01/2001 | WO2000032194A3 Use of niacin for the prevention of photocarcinogenesis and photoimmunosuppression |
| 02/01/2001 | WO2000009668A9 Engraftable human neural stem cells |
| 02/01/2001 | WO1999065461A9 Cationic amphiphile micellar complexes |
| 02/01/2001 | WO1999061040A9 USE OF α1β1 INTEGRIN RECEPTOR INHIBITORS AND TGF-β1 INHIBITORS IN THE TREATMENT OF KIDNEY DISEASE |
| 02/01/2001 | WO1998034604A8 ANTI-PARASITIC ACTION OF N,N-DIETHYL-m-TOLUAMIDE (DEET) AND FORMULATIONS THAT PROLONG ITS ACTIVITY IN THE SKIN |
| 02/01/2001 | DE19935771A1 Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with cyclic substructures in the side chains, to processes and intermediates for their preparation and to the use for the preparation of medicaments |
| 02/01/2001 | DE19935219A1 Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung Carboxamides, medicaments containing these compounds, their use and production |
| 02/01/2001 | DE19934944A1 Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen Cosmetic and dermatological preparations based on O / W emulsions |
| 02/01/2001 | DE19934432A1 Indolderivate Indole derivatives |
| 02/01/2001 | CA2718926A1 Methods of reducing microbial resistance to drugs |
| 02/01/2001 | CA2689694A1 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 02/01/2001 | CA2383017A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 02/01/2001 | CA2382755A1 Substituted oxoazaheterocyclyl compounds |
| 02/01/2001 | CA2380317A1 Human synthetases |
| 02/01/2001 | CA2380270A1 26 human prostate and prostate cancer associated proteins |
| 02/01/2001 | CA2380226A1 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | CA2380208A1 Tricyclic monosaccharide derivatives useful in treating acute ischemia-induced neurodegeneration |
| 02/01/2001 | CA2380192A1 Oligonucleotides for inhibiting the expression of human eg5 |
| 02/01/2001 | CA2380181A1 8-phenyl-6,9-dihydro-¬1,2,4|triazolo¬3,4-i|purin-5-one derivatives |
| 02/01/2001 | CA2379859A1 Novel method for preparing benzoperhydroisoindole compounds |
| 02/01/2001 | CA2379834A1 Enzyme catalyzed anti-infective therapeutic agents |
| 02/01/2001 | CA2379818A1 Catalytic anti-factor viii allo-antibodies |
| 02/01/2001 | CA2379659A1 Antisense modulation of pten expression |
| 02/01/2001 | CA2379398A1 Nociceptin receptor orl-1 agonists for use in treating cough |
| 02/01/2001 | CA2378953A1 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
| 02/01/2001 | CA2378860A1 Bicyclic antagonists selective for the .alpha.v.beta.3 integrin |
| 02/01/2001 | CA2378776A1 Use of long-chain n-alkyl derivatives of deoxynojirimycin and a glucocerebrosidase enzyme for the manufacture of medicament for the treatment of glycolipid storage diseases |
| 02/01/2001 | CA2378650A1 Process for the improvement of spermatozoa fertilization activity |
| 02/01/2001 | CA2378462A1 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 02/01/2001 | CA2378409A1 Control of crustacean infestation of aquatic animals |
| 02/01/2001 | CA2378403A1 Novel polynucleotides and method for the use thereof |
| 02/01/2001 | CA2378395A1 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 02/01/2001 | CA2378372A1 Oil-in-water emulsion with improved stability |
| 02/01/2001 | CA2378371A1 Use of etodolac to treat cancer |
| 02/01/2001 | CA2378328A1 Method of promoting bone growth with hyaluronic acid and growth factors |
| 02/01/2001 | CA2377024A1 Ophthalmic composition comprising ketotifen |
| 02/01/2001 | CA2376465A1 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 02/01/2001 | CA2375982A1 Th2 differentiation inhibitors |
| 01/31/2001 | EP1072687A2 Method for testing metastatic potential and method for screening compounds with metastasis-suppressing activity |
| 01/31/2001 | EP1072680A1 Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| 01/31/2001 | EP1072607A2 Purine L-nucleosides, analogs and uses therof |
| 01/31/2001 | EP1072604A1 Calcium complex of (4R)-4-bis(carboxy-kappa.O)methyl amino-.kappa.N-6,9-bis (carboxy-.kappa.O)methyl-1-(4,4-diphenylcyclohexyl)oxy-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan- 11-yl acid-.kappa.N6,.kappa.N9,.kappa.O11 1-oxidato(6-)-,hexahydrogen, corresponding salts, pharmaceutical composition containing such complex, its therapeutic use and its use as additive as diagnostic agent as well as a process for preparing the complex |
| 01/31/2001 | EP1072601A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072597A1 Pyrazoles and their use as endothelin antagonists |
| 01/31/2001 | EP1072596A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072595A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072594A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072592A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072587A1 Sulfonamide derivatives and drugs containing the same as the active ingredient |
| 01/31/2001 | EP1072269A1 Pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in vagina and the use thereof |
| 01/31/2001 | EP1072268A1 Pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in vagina and the use thereof |
| 01/31/2001 | EP1072267A1 Antibacterial agents |
| 01/31/2001 | EP1072266A1 Thienylazolylalcoxyethanamines, their preparation and their application as medicaments |
| 01/31/2001 | EP1072265A1 Use of plant polyphenols for treating iron overload |
| 01/31/2001 | EP1072264A1 Remedies for primary biliary cirrhosis |
| 01/31/2001 | EP1072263A1 Amide derivatives and nociceptin antagonists |
| 01/31/2001 | EP1072262A1 Dispersible fluoxetine tablet |
| 01/31/2001 | EP1072261A2 Felbinac-containing patch |
| 01/31/2001 | EP1072260A1 Transdermal systems for the release of muscarinic receptor antagonists and use thereof for treatement of smooth muscle spasms in urology |
| 01/31/2001 | EP1072255A2 Desferrioxamine oral delivery system |
| 01/31/2001 | EP1072254A1 Food compositions, compositions for oral cavity and medicinal compositions for preventing or treating periodontosis and method for preventing or treating periodontosis |
| 01/31/2001 | EP1072253A1 Oral compositions |
| 01/31/2001 | EP1072248A2 Cosmetic and dermatological compositions based on o/w emulsions |
| 01/31/2001 | EP1072198A1 Preparation especially for use as medicament and/or nutritional supplement |
| 01/31/2001 | EP1071959A2 Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway |
| 01/31/2001 | EP1071822A2 Fetal testing for prediction of low birth weight |
| 01/31/2001 | EP1071787A1 Tao protein kinases and methods of use |
| 01/31/2001 | EP1071783A2 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis |
| 01/31/2001 | EP1071764A1 ANTISENSE OLIGONUCLEOTIDES FOR THE INHIBITION OF INTEGRIN $g(a) v?-SUBUNIT EXPRESSION |
| 01/31/2001 | EP1071753A2 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
| 01/31/2001 | EP1071752A1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF |
| 01/31/2001 | EP1071749A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 01/31/2001 | EP1071745A2 Process for synthesizing cox-2 inhibitors |
| 01/31/2001 | EP1071709A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 01/31/2001 | EP1071702A1 Fatty acid derivatives of bile acids and bile acid derivatives |
| 01/31/2001 | EP1071701A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 01/31/2001 | EP1071699A1 Enhanced antisense modulation of icam-1 |
| 01/31/2001 | EP1071698A1 Nucleic acid sequences and proteins associated with aging |
| 01/31/2001 | EP1071696A1 Programmed cell death and caspase-12 |
| 01/31/2001 | EP1071694A1 Staphylococcus aureus spo0j2: polynucleotide and protein |
| 01/31/2001 | EP1071693A1 Novel crystalline forms of an antiviral benzimidazole compound |
| 01/31/2001 | EP1071686A1 Novel heterocyclic compounds |
| 01/31/2001 | EP1071684A1 IMIDAZO 1,2-a]PYRIDINES AS PERIPHERAL BENZODIAZEPINE RECEPTOR BINDING AGENTS |
| 01/31/2001 | EP1071680A1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 01/31/2001 | EP1071679A1 Novel heterocyclic compounds |